Fredun Pharmaceuticals has informedthat the meeting of the Board of Directors of the Company is scheduled on16/12/2023 ,inter alia, to consider and approve for fund raising upto Rs. 120crores by way of further public offer, right issue, ADR/GDR/FCCB, QIP, Debtissue, preferential issue or any other method.
The above information is a part of company’s filingssubmitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1653.80 |
| Dr. Reddys Lab | 1215.95 |
| Cipla | 1228.20 |
| Zydus Lifesciences | 927.75 |
| Lupin | 2307.30 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: